Anyone following DVAX??....Stock is moving higher on speculation FDA may lift clinical hold on Hepsilav.....Mkt cap is ridiculously low given their cash position...funded partnerships.. and pipeline... I think it has a far superior risk/reward profile than many of the stocks bandied about here.....
Market Data 
Markets 
AI
